The spring issue of the Canadian MPN Group Newsletter is now available.
“The Canadian MPN group represents an exciting opportunity for national inter-professional collaboration to improve patient care and identify new treatment options for those affected by this rare disease area.” — Dr. Vikas Gupta
MPN research in Canada is focused on stem cell-targeted therapies that build on our current understanding of the role of the JAK2 gene mutation.
Have questions about MPNs?
Read our FAQs.
Download the new MPN e-SIMPLE app, a clinical tool for MPN management
I work in the healthcare field
I’ve been diagnosed with an MPN or know someone who has
Read the Canadian MPN Group newsletter for the latest in the field.
Watch Dr Vikas Gupta speak about Stem Cell Transplant for Myelofibrosis in the JAK2 Inhibitor Era.
Download the new MPN eSimple app.
Tweets about #MPNSM OR from:@MPNGroupCanada